Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study

Detalles Bibliográficos
Autores principales: Assanto, Giovanni Manfredi, Totaro, Matteo, Poggiali, Rebecca, Delli Paoli, Adele, Annechini, Giorgia, D’Elia, Gianna Maria, Aji, Francesco, Petrucci, Luigi, Fazio, Francesca, Del Giudice, Ilaria, Martelli, Maurizio, Micozzi, Alessandra, Gentile, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2023
Materias:
Scientific Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631717/
https://www.ncbi.nlm.nih.gov/pubmed/38028390
http://dx.doi.org/10.4084/MJHID.2023.061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631717/
https://www.ncbi.nlm.nih.gov/pubmed/38028390
http://dx.doi.org/10.4084/MJHID.2023.061

Ejemplares similares